| pubmed-article:19884546 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19884546 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:19884546 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:19884546 | lifeskim:mentions | umls-concept:C1519522 | lld:lifeskim |
| pubmed-article:19884546 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:19884546 | lifeskim:mentions | umls-concept:C1517503 | lld:lifeskim |
| pubmed-article:19884546 | pubmed:issue | 34 | lld:pubmed |
| pubmed-article:19884546 | pubmed:dateCreated | 2009-11-26 | lld:pubmed |
| pubmed-article:19884546 | pubmed:abstractText | As a result of the questionable risk-to-benefit ratio of adjuvant therapies, stage II melanoma is currently managed by observation because available clinicopathologic parameters cannot identify the 20% to 60% of such patients likely to develop metastatic disease. Here, we propose a multimarker molecular prognostic assay that can help triage patients at increased risk of recurrence. | lld:pubmed |
| pubmed-article:19884546 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19884546 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19884546 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19884546 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19884546 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:CampRobert... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:RimmDavid LDL | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:AriyanStephan... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:SubtilAntonio... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:Gould... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:BergerAaron... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:KlugerHarriet... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:MolinaroAnnet... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:KrauthammerMi... | lld:pubmed |
| pubmed-article:19884546 | pubmed:author | pubmed-author:BradleyWillia... | lld:pubmed |
| pubmed-article:19884546 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19884546 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19884546 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19884546 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19884546 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19884546 | pubmed:pagination | 5772-80 | lld:pubmed |
| pubmed-article:19884546 | pubmed:dateRevised | 2011-3-3 | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:meshHeading | pubmed-meshheading:19884546... | lld:pubmed |
| pubmed-article:19884546 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19884546 | pubmed:articleTitle | Melanoma prognostic model using tissue microarrays and genetic algorithms. | lld:pubmed |
| pubmed-article:19884546 | pubmed:affiliation | Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA. | lld:pubmed |
| pubmed-article:19884546 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19884546 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19884546 | lld:pubmed |
